Table 2.

Competing risk analysis in patients with testicular cancer

Variables	Gray’s test	p-Value	Cumulative incidence function
			12-months	60-months	120-months
AJCC Stage	55.74	< 0.0001
I			0.024	0.081	0.336
II			0.052	0.195	0.591
III			0.069	0.176	0.356